In response to its detailed reply submitted in October 2016
Vista Pharmaceuticals announced that the Company has been issued a warning letter by the United States Food and Drug Administration (USFDA), in response to its detailed reply submitted in October 2016. The Company will respond with complete details of remedial action to USFDA before the stipulated date.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
